Kaken assumes ownership of Aadi Sub, including the Aadi Bioscience name, trademarks and the FYARRO ® (sirolimus protein-bound particles for injectable suspension) (albumin-bound) business.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback